MSB 5.12% $1.39 mesoblast limited

Ann: Novartis and Mesoblast Remestemcel-L Collaboration, page-29

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 7,185 Posts.
    lightbulb Created with Sketch. 1836
    Congratulations to all SH. This is big.

    Novartis gave us a tick... well more than that - millions

    The medicine is going to serve the patients it is aimed at.

    Nov wouldn’t sign the dotted line until they were convinced that the medicine wouldn’t have any negative impacts opening them up to billion dollar litigations and reputations loss.

    FDA- you are up next to give the go!
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.